{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:40:15Z","timestamp":1790390415019,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ejphar.2014.02.001","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T22:32:46Z","timestamp":1392157966000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme"],"prefix":"10.1016","volume":"728","author":[{"given":"Ahmed","family":"Tayel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled H.","family":"Abd El Galil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal M.","family":"El-Gayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.H.","family":"Al-Gayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.02.001_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jopr.2013.07.016","article-title":"Measuring serum levels of glycosaminoglycans for prediction and using viscum fraxini-2 for treatment of patients with hepatocellular carcinoma","volume":"7","author":"Al-Gayyar","year":"2013","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.ejphar.2014.02.001_bib2","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/sj.onc.1209550","article-title":"New therapies for hepatocellular carcinoma","volume":"25","author":"Avila","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2014.02.001_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.21495","article-title":"Role of caspase-8 in hepatocyte response to infection and injury in mice","volume":"45","author":"Ben Moshe","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2014.02.001_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000335472","article-title":"Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma","volume":"81","author":"Cheng","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2014.02.001_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2875-11-69","article-title":"Extracellular ATP triggers proteolysis and cytosolic Ca(2)(+) rise in Plasmodium berghei and Plasmodium yoelii malaria parasites","volume":"11","author":"Cruz","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ejphar.2014.02.001_bib6","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0959-8049(96)00139-6","article-title":"Suramin-induced neutropenia","volume":"32A","author":"Dawson","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2014.02.001_bib7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1172\/JCI107659","article-title":"Superoxide dismutase activity in leukocytes","volume":"53","author":"DeChatelet","year":"1974","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2014.02.001_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/00498259009046905","article-title":"A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde","volume":"20","author":"Draper","year":"1990","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2014.02.001_bib9","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1042\/bj0271824","article-title":"A colorimetric method for the determination of glucosamine and chondrosamine","volume":"27","author":"Elson","year":"1933","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2014.02.001_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10495-009-0333-y","article-title":"Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling","volume":"14","author":"Fang","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejphar.2014.02.001_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1389557043403729","article-title":"The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation","volume":"4","author":"Ferro","year":"2004","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.ejphar.2014.02.001_bib12","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1083\/jcb.111.4.1651","article-title":"Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor","volume":"111","author":"Flaumenhaft","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib13","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2014.02.001_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tibs.2009.06.005","article-title":"Heparanase: busy at the cell surface","volume":"34","author":"Fux","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2014.02.001_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1096-9071(199903)57:3<238::AID-JMV5>3.0.CO;2-G","article-title":"Suramin blocks hepatitis C binding to human hepatoma cells in vitro","volume":"57","author":"Garson","year":"1999","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib16","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","article-title":"Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis","volume":"14","author":"Gomaa","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.112.199919","article-title":"Suramin decreases injury and improves regeneration of ethanol-induced steatotic partial liver grafts","volume":"344","author":"He","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.02.001_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/11595360-000000000-00000","article-title":"Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin","volume":"25","author":"Ho","year":"2011","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejphar.2014.02.001_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbrc.2010.10.089","article-title":"The NMR solution structure of human epidermal growth factor (hEGF) at physiological pH and its interactions with suramin","volume":"402","author":"Huang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2014.02.001_bib20","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.biocel.2006.06.004","article-title":"Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis","volume":"38","author":"Ilan","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0168-8278(02)00011-9","article-title":"Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality","volume":"36","author":"Li","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3892\/ijo.2012.1510","article-title":"Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling","volume":"41","author":"Liang","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib23","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1053\/j.gastro.2011.08.037","article-title":"Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury","volume":"141","author":"Liedtke","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2014.02.001_bib24","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1242\/dev.126.17.3715","article-title":"Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development","volume":"126","author":"Lin","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.ejphar.2014.02.001_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/157488411796151174","article-title":"Tissue protective and anti-fibrotic actions of suramin: new uses of an old drug","volume":"6","author":"Liu","year":"2011","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib26","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archderm.1995.01690220053010","article-title":"Cutaneous eruptions from suramin. A clinical and histopathologic study of 60 patients","volume":"131","author":"Lowitt","year":"1995","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ijc.10930","article-title":"Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues","volume":"104","author":"Marchetti","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2014.02.001_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0707182","article-title":"Heparanase: a target for drug discovery in cancer and inflammation","volume":"151","author":"McKenzie","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/clinchem\/8.4.378","article-title":"Interferences in the colorimetric determination of glucuronic acid in blood serum","volume":"8","author":"Mosher","year":"1962","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2014.02.001_bib30","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1016\/S0021-9258(18)92871-1","article-title":"Suramin. A potent inhibitor of melanoma heparanase and invasion","volume":"266","author":"Nakajima","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.02.001_bib31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","article-title":"Experimental models of hepatocellular carcinoma","volume":"48","author":"Newell","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0945-053X(01)00184-6","article-title":"Hyaluronan and its catabolic products in tissue injury and repair","volume":"21","author":"Noble","year":"2002","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib33","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1248\/bpb.29.1810","article-title":"Biochemical characterization of suramin as a selective inhibitor for the PKA-mediated phosphorylation of HBV core protein in vitro","volume":"29","author":"Okabe","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2014.02.001_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","article-title":"FGFs, heparan sulfate and FGFRs: complex interactions essential for development","volume":"22","author":"Ornitz","year":"2000","journal-title":"Bioessays"},{"key":"10.1016\/j.ejphar.2014.02.001_bib35","first-page":"M99","article-title":"Heparanase: a key enzyme involved in cell invasion","volume":"1471","author":"Parish","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2014.02.001_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/modpathol.3800146","article-title":"Overexpression of caspase-3 in hepatocellular carcinomas","volume":"17","author":"Persad","year":"2004","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/bjc.1992.272","article-title":"Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity","volume":"66","author":"Pesenti","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2014.02.001_bib38","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0002-9440(10)64779-7","article-title":"Mechanisms of apoptosis","volume":"157","author":"Reed","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-1281(11)80092-9","article-title":"Morphohistochemical relationships between adrenal cortex and major salivary glands in response to chronic suramin treatment","volume":"97","author":"Ricciardi","year":"1995","journal-title":"Acta Histochem."},{"key":"10.1016\/j.ejphar.2014.02.001_bib40","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1038\/sj.onc.1209549","article-title":"RNA interference-mediated prevention and therapy for hepatocellular carcinoma","volume":"25","author":"Romano","year":"2006","journal-title":"Oncogene"},{"issue":"suppl 1","key":"10.1016\/j.ejphar.2014.02.001_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000122603","article-title":"Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma","volume":"51","author":"Sakamoto","year":"2008","journal-title":"Intervirology"},{"key":"10.1016\/j.ejphar.2014.02.001_bib42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/jcb.20602","article-title":"Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies","volume":"96","author":"Sanderson","year":"2005","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.ejphar.2014.02.001_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc842","article-title":"Roles of heparan-sulphate glycosaminoglycans in cancer","volume":"2","author":"Sasisekharan","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2014.02.001_bib44","doi-asserted-by":"crossref","first-page":"G498","DOI":"10.1152\/ajpgi.00525.2011","article-title":"Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP","volume":"303","author":"Schattenberg","year":"2012","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib45","first-page":"64","article-title":"Use of adaptive control with feedback to individualize suramin dosing","volume":"52","author":"Scher","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2014.02.001_bib46","doi-asserted-by":"crossref","first-page":"e76867","DOI":"10.1371\/journal.pone.0076867","article-title":"microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection","volume":"8","author":"Spaniel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.02.001_bib47","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/bph.12302","article-title":"Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3","volume":"170","author":"Subramaniam","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.ejphar.2014.02.001_bib48","first-page":"37","article-title":"Mammalian heparanase as mediator of tumor metastasis and angiogenesis","volume":"2","author":"Vlodavsky","year":"2000","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.ejphar.2014.02.001_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","article-title":"Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis","volume":"108","author":"Vlodavsky","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2014.02.001_bib50","first-page":"60","article-title":"Properties and function of heparanase in cancer metastasis and angiogenesis","volume":"31","author":"Vlodavsky","year":"2001","journal-title":"Haemostasis"},{"key":"10.1016\/j.ejphar.2014.02.001_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/scbi.2001.0420","article-title":"Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development","volume":"12","author":"Vlodavsky","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib52","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2174\/138161207781039742","article-title":"Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate","volume":"13","author":"Vlodavsky","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2014.02.001_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1582-4934.2007.00039.x","article-title":"Mammalian heparanase: what is the message?","volume":"11","author":"Vreys","year":"2007","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2014.02.001_bib54","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.3748\/wjg.v17.i42.4675","article-title":"Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization","volume":"17","author":"Wang","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib55","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.mehy.2005.12.043","article-title":"Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed?","volume":"66","author":"Wu","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2014.02.001_bib56","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10571-011-9698-x","article-title":"Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2","volume":"31","author":"Yoshino","year":"2011","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2014.02.001_bib57","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1631\/jzus.2006.B0608","article-title":"Antitumor activities of d-glucosamine and its derivatives","volume":"7","author":"Zhang","year":"2006","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.ejphar.2014.02.001_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.fct.2013.10.043","article-title":"The activation of p38 and JNK by ROS, contribute to OLO-2-mediated intrinsic apoptosis in human hepatocellular carcinoma cells","volume":"63","author":"Zhang","year":"2014","journal-title":"Food Chem. Toxicol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T09:52:28Z","timestamp":1648288348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":58,"alternative-id":["S0014299914001150"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.02.001","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}